# Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

Study · id `cardio:ct-nct04676880` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04676880](<https://clinicaltrials.gov/study/NCT04676880>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04676880

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 609 participants.

## Technical summary

Registry record NCT04676880. Randomized; no masking; primary purpose prevention. Start 2021-01-01 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 609 participants (planned count; ClinicalTrials.gov record NCT04676880, source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)
- Started: 2021-01-01 (actual) (ClinicalTrials.gov record NCT04676880, source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)
- Primary completion: 2026-05-01 (anticipated) (ClinicalTrials.gov record NCT04676880, source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)
- Completion: 2026-11-01 (anticipated) (ClinicalTrials.gov record NCT04676880, source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)
- Countries: Netherlands (ClinicalTrials.gov record NCT04676880, source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04676880-2024-06-21`, retrieved 2026-11-18)

## The registry's words

- Brief title: Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
- Acronym: COMPARE-LAAO
- Condition: Atrial Fibrillation
- Condition: Anticoagulants and Bleeding Disorders
- Intervention (Device): Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
- Lead sponsor: R&D Cardiologie
- Lead sponsor class: OTHER
- Collaborator: ZonMw: The Netherlands Organisation for Health Research and Development
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Left atrial appendage occlusion (`cardio:left-atrial-appendage-occlusion`)
- Registry lists this organization as the lead sponsor: R&D Cardiologie (`cardio:org-r-d-cardiologie`)
- Registry lists this organization as a collaborator: ZonMw: The Netherlands Organisation for Health Research and Development (`cardio:org-zonmw-the-netherlands-organisation-for-health-research-and-cc2e75`)

## Provenance

Content hash: 69bdf21058f482dce5659aab6c694d9c8fbd64ad8ab636746019603db73240aa
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
